Literature DB >> 24445560

Methadone patient-controlled analgesia for postoperative pain: a randomized, controlled, double-blind study.

José Osvaldo Barbosa Neto1, Maria Deneb Tavares Machado, Marta de Almeida Correa, Hamilton Alves Scomparim, Irimar Paula Posso, Hazem Adel Ashmawi.   

Abstract

PURPOSE: Postoperative pain is an important health-care issue. Patient-controlled analgesia (PCA) is considered the gold standard for systemic postoperative pain treatment. Methadone PCA is used for patients with chronic pain and those in the palliative care setting. However, its efficacy as a first-line drug for acute postoperative pain is unknown. This study evaluated the use of postoperative methadone PCA after total hip arthroplasty (THA) compared with morphine PCA.
METHODS: This was a randomized, double-blind, controlled, parallel-group study. Patients were randomized into two groups: group methadone--methadone PCA, and group morphine--morphine PCA, for postoperative analgesia. Drugs were delivered through PCA pumps throughout the first 24 h after surgery (T1:6, T2:12, T3:18, T4:24 h).
RESULTS: Opioid consumption in 24 h was significantly lower for group methadone than for group morphine. Group methadone patients experienced significantly less pain than group morphine at rest. Pain after movement was significantly lower in group methadone at T1 and T3 and marginally lower at T2 and T4. Adverse events more frequently reported were sleepiness, nausea, and vomiting, but no statistical difference between groups was found.
CONCLUSION: This study demonstrated that methadone PCA prompted less opioid consumption and lower pain scores at rest and at motion in comparison with morphine PCA as postoperative analgesia after THA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24445560     DOI: 10.1007/s00540-013-1785-3

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  23 in total

Review 1.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  The measurement of clinical pain intensity: a comparison of six methods.

Authors:  Mark P Jensen; Paul Karoly; Sanford Braver
Journal:  Pain       Date:  1986-10       Impact factor: 6.961

3.  [Ventricular tachycardia with 2 variable opposing foci].

Authors:  F Dessertenne
Journal:  Arch Mal Coeur Vaiss       Date:  1966-02

Review 4.  Treatment of acute postoperative pain.

Authors:  Christopher L Wu; Srinivasa N Raja
Journal:  Lancet       Date:  2011-06-25       Impact factor: 79.321

5.  Intravenous methadone in the management of chronic cancer pain: safe and effective starting doses when substituting methadone for fentanyl.

Authors:  J Santiago-Palma; N Khojainova; C Kornick; D J Fischberg; L H Primavera; R Payne; P Manfredi
Journal:  Cancer       Date:  2001-10-01       Impact factor: 6.860

6.  CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

Authors:  Kenneth F Schulz; Douglas G Altman; David Moher
Journal:  BMJ       Date:  2010-03-23

7.  Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.

Authors:  Sebastiano Mercadante; Giampiero Porzio; Patrizia Ferrera; Fabio Fulfaro; Federica Aielli; Lucilla Verna; Patrizia Villari; Corrado Ficorella; Vittorio Gebbia; Salvatore Riina; Alessandra Casuccio; Salvatore Mangione
Journal:  Eur J Pain       Date:  2008-03-18       Impact factor: 3.931

Review 8.  Consensus guideline on parenteral methadone use in pain and palliative care.

Authors:  Lauren Shaiova; Ann Berger; Craig D Blinderman; Eduardo Bruera; Mellar P Davis; Susan Derby; Charles Inturrisi; Jill Kalman; Davendra Mehta; Marco Pappagallo; Eugene Perlov
Journal:  Palliat Support Care       Date:  2008-06

9.  Patient-controlled versus scheduled, nurse-administered analgesia following vaginal reconstructive surgery: a randomized trial.

Authors:  Catrina C Crisp; Sindura Bandi; Steven D Kleeman; Susan H Oakley; Christine M Vaccaro; Maria V Estanol; Angela N Fellner; Rachel N Pauls
Journal:  Am J Obstet Gynecol       Date:  2012-06-20       Impact factor: 8.661

10.  QTc interval prolongation associated with intravenous methadone.

Authors:  Craig A Kornick; Michael J Kilborn; Juan Santiago-Palma; Glenn Schulman; Howard T Thaler; Deborah L Keefe; Alexander N Katchman; John C Pezzullo; Steven N Ebert; Raymond L Woosley; Richard Payne; Paolo L Manfredi
Journal:  Pain       Date:  2003-10       Impact factor: 6.961

View more
  5 in total

1.  A Practical Approach to Acute Postoperative Pain Management in Chronic Pain Patients.

Authors:  Edwin N Aroke; Susan P McMullan; Katie O Woodfin; Ryan Richey; Jordan Doss; Bryan A Wilbanks
Journal:  J Perianesth Nurs       Date:  2020-07-11       Impact factor: 1.084

Review 2.  Methadone for Pain Management: A Pharmacotherapeutic Review.

Authors:  Denise Kreutzwiser; Qutaiba A Tawfic
Journal:  CNS Drugs       Date:  2020-08       Impact factor: 5.749

Review 3.  The Effect of Intraoperative Methadone Compared to Morphine on Postsurgical Pain: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Mark C Kendall; Lucas J Alves; Kristi Pence; Taif Mukhdomi; Daniel Croxford; Gildasio S De Oliveira
Journal:  Anesthesiol Res Pract       Date:  2020-03-27

4.  Low-dose methadone for refractory chronic migraine accompanied by medication-overuse headache: a prospective cohort study.

Authors:  Silvia Benemei; Chiara Lupi; Francesco De Cesaris; Niccolò Lombardi; Alessandra Bettiol; Alberto Chiarugi; Pierangelo Geppetti; Valentina Galli; Chiara Pracucci; Brunella Occupati; Guido Mannaioni
Journal:  Neurol Sci       Date:  2020-07-20       Impact factor: 3.307

5.  [Comparison of postoperative analgesia with methadone versus morphine in cardiac surgery].

Authors:  Ana Carolina Carvalho; Fábio Jean Goulart Sebold; Patrícia Mello Garcia Calegari; Benhur Heleno de Oliveira; Fabiana Schuelter-Trevisol
Journal:  Braz J Anesthesiol       Date:  2017-10-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.